The primary unit of tuberculosis (TB) medical care in China is the county TB dispensary or county designated hospital (CTD), where patients can receive free diagnosis and treatment. However, a substantial number of patients seek their anti-TB treatment from general health facilities (Non-CTDs). This study aimed to investigate the first anti-TB treatment experience and choice of health facilities of retreated TB patients and their determinants.
A cross-sectional study was conducted in Jiangsu, Shandong and Sichuan provinces. All registered re-treated TB patients were investigated using a structured questionnaire covering information on demographics, socio-economic characteristics, and previous anti-TB treatment experiences.
Totally, 75.3% of 544 patients visited CTD directly for initial treatment. Patients who were female (OR:1.71, 95% CI: 1.01-2.87), over 40 years of age (OR:2.80, 95% CI: 1.24-6.33), from Jiangsu (OR:3.07, 95% CI: 1.57-6.01) and Sichuan (OR:4.47, 95% CI: 2.29-8.73) and those diagnosed before 2005 (OR:6.87, 95% CI: 4.24-11.13) had a significant higher risk receiving their initial treatment at a non-CTD. Patients were more likely to have standardized diagnosis and treatment regimens in CTD (89.8%) than in non-CTDs (65.9%). Patients treated in non-CTDs versus in CTD had a lower possibility to complete their treatment course during first TB episode (χ 2 = 3.926, P = 0.048), but there was no significant difference in the cure rate between different facilities (CTD 60.8%, Non-CTDs 59.1%). Patients in non-CTDs incurred higher costs (1,360 CNY) than those treated in CTD (920CNY).
CTD play a key role in the National Tuberculosis Control Program. Patients should be guided to seek health care in county designated hospital, where they are more likely to receive appropriate examinations, treatment regimens and rigorous supervision, and to bear a lighter economic burden.
World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015.
World Health Organization W. Tuberculosis in China: WHO/HTM/TB. http://www.wpro.who.int/china/mediacentre/factsheets/tuberculosis/en/. Accessed 12 Jan 2016.
MOHO China. Nationwide anti-tuberculosis drug resistant baseline surveillance in China (2007–2008). Beijing: People’s Public Health Press; 2010.
National Bureau of Statistics of China. New Statistical Year books2015. Beijing: China Statistics Press; 2016. http://www.stats.gov.cn/tjsj/ndsj/2015/indexch.htm.
Xu B, Zhao Q, Hu Y, Shi Y, Wang W, Diwan VK. Experiences in anti-tuberculosis treatment in patients with multiple previous treatments and its impact on drug resistant tuberculosis epidemics. Glob Health Action. 2014;7:24593. PubMed
National Bureau Of Statistics P. Chinese statistical yearbook 2011. Beijing: China Statistical Publishing House; 2011.
WHO. International Standards for Tuberculosis care. Geneva: World Health Organization; 2007.
Akishinonomiya K. [Women's knowledge, perceptions, beliefs, and behaviors related to tuberculosis: results from a survey with participants of seminars held by the National Federation of Community Women's Organizations for Tuberculosis Control]. Kekkaku. 2012;87(10):623–33. PubMed
WHO. The Stop TB Strategy. Geneva: World Health Organization; 2006.
Cao JP, Zhang LY, Zhu JQ, Chin DP. Two-year follow-up of directly-observed intermittent regimens for smear-positive pulmonary tuberculosis in China. Int J Tuberc Lung Dis. 1998;2(5):360–4. PubMed
Xue HG, van den Hof S, van der Werf MJ, et al. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Infect Dis. 2011;52(7):e153–6. CrossRef
- Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Sommerakademie-Visual, Mail Icon II